Use your antibodies-online credentials, if available.
No Products on your Comparison List.
Your basket is empty.
Find out more
CR1L encodes a membrane-bound inhibitor of complement activation, which contains several tandemly arranged short consensus repeats (SCRs) of approximately 60 amino acids. Additionally we are shipping Complement Component (3b/4b) Receptor 1-Like Antibodies (23) and Complement Component (3b/4b) Receptor 1-Like Kits (7) and many more products for this protein.
Showing 2 out of 3 products:
CR1L transcript appears to be limited to hematopoietic and fetal lymphoid tissue.
CRRY role in the retinal epithelium and photoreceptor degeneration
Factor H (show CFH Proteins) and Crry are critical for regulating complement activation at distinct anatomic sites within the kidney.
this study has provided direct evidence for a role of Crry in controlling spontaneous alternative pathway complement activation on renal tubular epithelial cells.
HBx can up-regulate CD59 (show CD59 Proteins) and Crry expression in podocytes through activating the P38 (show CRK Proteins) pathway.
Crry costimulation enhanced the in vitro expansion of natural Treg cells while maintaining their phenotypic and suppressive properties. Crry-expanded Treg cells decreasing antigen-dependent secretion of cytokines.
Stmn2 (show STMN2 Proteins) and the chromosome 14 Rarb (show RARB Proteins) region, but not Cr1 (show TDGF1 Proteins) or Clu (show CLU Proteins) or Picalm (show PICALM Proteins), have roles in prion (show PRNP Proteins) disease.
There is a significant reduction in the numbers of both neutrophils and macrophages in cardiac isografts isolated from mice treated with either complement receptor 2-Crry or CR2-factor H (show CFH Proteins).
Crry is clearly present in the placentas from spontaneous abortions in mice.
Crry is the only membrane-bound complement regulator expressed on the basolateral surface of murine renal tubular epithelial cells under in vitro culture conditions.
Data show that a single-nucleotide polymorphism in the first short consensus repeat of Sle1c Crry introduced a novel N-linked glycosylation site likely responsible for structural alteration.
This gene encodes a membrane-bound inhibitor of complement activation, which contains several tandemly arranged short consensus repeats (SCRs) of approximately 60 amino acids. The encoded protein may play a role in tumor immune surveillance, which is unrelated to complement inhibition. Three alternatively spliced transcript variants encoding distinct isoforms have been found for this gene.
complement component (3b/4b) receptor 1-like
, complement regulatory GPI-anchor protein
, 5I2 antigen
, Complement receptor related protein
, antigen 5I2
, complement component receptor 1-like protein
, complement receptor type 1
, complement regulatory protein Crry
, complement C4b-binding protein CR-1-like protein
, complement receptor related protein
, protein p65